Search alternatives:
linear decrease » linear increase (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
linear decrease » linear increase (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
7301
Changes in the platelet count.
Published 2025“…</p><p>Methods</p><p>This is a single-center, prospective, randomized controlled study conducted from June 1, 2021, to October 31, 2022 on patients diagnosed with locally advanced NPC. …”
-
7302
Changes in the white blood cell count.
Published 2025“…</p><p>Methods</p><p>This is a single-center, prospective, randomized controlled study conducted from June 1, 2021, to October 31, 2022 on patients diagnosed with locally advanced NPC. …”
-
7303
Changes in the hemoglobin.
Published 2025“…</p><p>Methods</p><p>This is a single-center, prospective, randomized controlled study conducted from June 1, 2021, to October 31, 2022 on patients diagnosed with locally advanced NPC. …”
-
7304
WBC and ANC on day 7 post-chemotherapy.
Published 2025“…</p><p>Methods</p><p>This is a single-center, prospective, randomized controlled study conducted from June 1, 2021, to October 31, 2022 on patients diagnosed with locally advanced NPC. …”
-
7305
General clinical data of 88 patients with NPC.
Published 2025“…</p><p>Methods</p><p>This is a single-center, prospective, randomized controlled study conducted from June 1, 2021, to October 31, 2022 on patients diagnosed with locally advanced NPC. …”
-
7306
CONSORT participant flow diagram.
Published 2025“…</p><p>Methods</p><p>This is a single-center, prospective, randomized controlled study conducted from June 1, 2021, to October 31, 2022 on patients diagnosed with locally advanced NPC. …”
-
7307
S4 File -
Published 2025“…</p><p>Methods</p><p>This is a single-center, prospective, randomized controlled study conducted from June 1, 2021, to October 31, 2022 on patients diagnosed with locally advanced NPC. …”
-
7308
Renal function and risk of dementia: a Mendelian randomization study
Published 2024“…</p> <p>The findings indicate a significant correlation between each unit increase in cystatin C-based estimated glomerular filtration rate (eGFR-cys) levels was significantly associated with a reduction in the incidence of late-onset Alzheimer’s disease (LOAD) (IVW: OR = 0.35, 95% CI: 0.13–0.91, <i>p</i> = 0.031). …”
-
7309
-
7310
Experimental Investigation of Hydrodynamic Characteristics in Industrial Pulsed Liquid–Liquid Extraction Column
Published 2025“…An industrial-scale experimental setup featuring a glass pulsed extraction column has been constructed to investigate the effects of pulsation intensity and flow rate on the flow regime, holdup, and mean residence time (MRT) distribution of the dispersed phase in the extraction columns. …”
-
7311
Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx
Published 2024“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
-
7312
Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx
Published 2024“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
-
7313
Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx
Published 2024“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
-
7314
Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx
Published 2024“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
-
7315
Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx
Published 2024“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
-
7316
Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx
Published 2024“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
-
7317
Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx
Published 2024“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
-
7318
Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX
Published 2024“…</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
-
7319
Table 1_A national framework for transition to precision medicine.docx
Published 2025“…The statistical sample of the study comprised PM specialists, researchers, and patients whose PM plays a significant role in their diagnosis and treatment. …”
-
7320
Data Sheet 1_Lipoxin A4 levels correlate with severity in a Spanish COVID-19 cohort: potential use of endogenous pro-resolving mediators as biomarkers.docx
Published 2025“…We found reduced levels in deceased patients when compared to mild or severe patients, concomitant with a decrease in the LXA<sub>4</sub> biosynthetic pathway and an increase in its degradation pathway. …”